27,185 Shares in CME Group Inc. $CME Acquired by Tulsa Wealth Advisors INC

Tulsa Wealth Advisors INC acquired a new stake in CME Group Inc. (NASDAQ:CME) during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm acquired 27,185 shares of the financial services provider’s stock, valued at approximately $7,424,000. CME Group makes up about 2.5% of Tulsa Wealth Advisors INC’s investment portfolio, making the stock its 10th largest position.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in CME. Norges Bank acquired a new stake in shares of CME Group in the fourth quarter valued at about $1,523,241,000. Sanders Capital LLC acquired a new position in CME Group during the third quarter worth about $1,006,932,000. Strive Asset Management LLC acquired a new position in CME Group during the third quarter worth about $636,487,000. Victory Capital Management Inc. grew its stake in CME Group by 746.4% during the 4th quarter. Victory Capital Management Inc. now owns 2,049,649 shares of the financial services provider’s stock valued at $559,720,000 after acquiring an additional 1,807,491 shares in the last quarter. Finally, Life Cycle Investment Partners Ltd purchased a new stake in CME Group during the 4th quarter valued at about $217,656,000. Hedge funds and other institutional investors own 87.75% of the company’s stock.

Wall Street Analysts Forecast Growth

CME has been the topic of a number of research reports. Wall Street Zen raised shares of CME Group from a “sell” rating to a “hold” rating in a research note on Saturday, June 13th. Weiss Ratings downgraded CME Group from a “buy (a-)” rating to a “buy (b+)” rating in a research report on Thursday, June 11th. Morgan Stanley lowered their price objective on CME Group from $362.00 to $353.00 and set an “overweight” rating on the stock in a research note on Thursday, April 23rd. Keefe, Bruyette & Woods raised CME Group from a “market perform” rating to an “outperform” rating and set a $305.00 target price for the company in a research note on Thursday. Finally, Barclays reduced their price target on CME Group from $343.00 to $316.00 and set an “equal weight” rating on the stock in a report on Thursday, April 23rd. Twelve investment analysts have rated the stock with a Buy rating, four have issued a Hold rating and two have issued a Sell rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $305.18.

CME Group Price Performance

Shares of CME opened at $246.38 on Friday. The company’s 50-day moving average price is $279.61 and its 200 day moving average price is $287.21. CME Group Inc. has a 12-month low of $244.56 and a 12-month high of $329.16. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.13. The firm has a market cap of $89.28 billion, a P/E ratio of 21.02, a price-to-earnings-growth ratio of 2.75 and a beta of 0.21.

CME Group (NASDAQ:CME) last announced its earnings results on Wednesday, April 22nd. The financial services provider reported $3.36 earnings per share for the quarter, topping the consensus estimate of $3.11 by $0.25. The company had revenue of $1.88 billion during the quarter, compared to analyst estimates of $1.77 billion. CME Group had a net margin of 63.19% and a return on equity of 15.42%. CME Group’s revenue was up 14.5% compared to the same quarter last year. During the same quarter last year, the firm posted $2.80 earnings per share. On average, sell-side analysts forecast that CME Group Inc. will post 12.28 earnings per share for the current year.

CME Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, June 25th. Investors of record on Tuesday, June 9th will be given a dividend of $1.30 per share. The ex-dividend date of this dividend is Tuesday, June 9th. This represents a $5.20 dividend on an annualized basis and a dividend yield of 2.1%. CME Group’s dividend payout ratio (DPR) is presently 44.37%.

CME Group News Summary

Here are the key news stories impacting CME Group this week:

• Positive Sentiment: CME continues to be highlighted as a dividend and value stock, with analysts noting its strong capital returns, electronic trading growth, and global product expansion could support a long-term rebound. Article Title
• Positive Sentiment: One market note said CME may be undervalued after the CEO succession announcement, suggesting the stock could have upside if investors view the leadership transition as orderly. Article Title
• Neutral Sentiment: CME named longtime finance chief Julie Winkler as its next CEO, while Terry Duffy will step into an executive chairman role; the move appears planned and may reduce uncertainty, but it also marks a major leadership change. Article Title
• Neutral Sentiment: The company is also taking legal action against the CFTC over approval of perpetual crypto futures, arguing the products should be treated as swaps rather than futures. The case could affect CME’s role in crypto derivatives, but the financial impact is still uncertain. Article Title
• Negative Sentiment: Goldman Sachs kept a Sell rating on CME and trimmed its price target, citing leadership transition risk and regulatory uncertainty, which may be weighing on sentiment. Article Title

Insider Activity at CME Group

In other news, CEO Terrence A. Duffy sold 35,000 shares of the firm’s stock in a transaction on Friday, May 15th. The stock was sold at an average price of $298.51, for a total transaction of $10,447,850.00. Following the completion of the transaction, the chief executive officer directly owned 55,630 shares in the company, valued at $16,606,111.30. This trade represents a 38.62% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, insider Hilda Harris Piell sold 5,753 shares of the business’s stock in a transaction on Monday, May 18th. The shares were sold at an average price of $304.63, for a total value of $1,752,536.39. Following the completion of the sale, the insider owned 27,702 shares in the company, valued at $8,438,860.26. This represents a 17.20% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. 0.30% of the stock is currently owned by company insiders.

CME Group Profile

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.